Telomerase stability and evaluation of real-time telomeric repeat amplification protocol
Samo za registrovane korisnike
2019
Autori
Vukašinović, AleksandraKotur-Stevuljević, Jelena

Mlakar, Vid
Sopić, Miron

Cvetković, Zorica P.
Petković, Miloš

Spasojević-Kalimanovska, Vesna

Bogavac-Stanojević, Nataša

Ostanek, Barbara

Članak u časopisu (Objavljena verzija)

Metapodaci
Prikaz svih podataka o dokumentuApstrakt
Telomerase is RNA directed polymerase which acts as reverse transcriptase based on its own RNA component. It is considered to be involved in the pathology of many diseases and is recognized as a potential biomarker. The aims were to determine the sample storage conditions and the time frame for samples analysis, then to prove reliability of enzyme activity measurement with real-time telomeric repeat amplification protocol (TRAP) and to evaluate the suitable standard samples for telomerase activity measurements. Samples used for stability and freeze-thaw study were peripheral blood leukocytes, obtained from apparently healthy persons, patients with diagnosed cancer and cell lines. Telomerase activity was measured using TRAP method, while standard evaluation was done using nuclear magnetic resonance (NMR) technique. Storage at -20 degrees C preserved telomerase activity in samples from cancer patients for at least 14 days (21.46 +/- 0.135 versus 21.84 +/- 0.357, p = .756), while samples ...obtained from healthy persons should be stored at -80 degrees C. We observed significant decrease of telomerase activity at freeze thaw cycle 5 in cancer patients' samples (21.46 +/- 0.135 versus 23.09 +/- 0.316, p lt .05), and in healthy persons' ones already at cycle 3 (22.74 +/- 0.107 versus 24.85 +/- 0.151, p lt .05). Telomerase activity from cell lines samples showed overall greater stability regarding the storage period and freeze-thaw cycles and it was considered for standard sample, which was confirmed by NMR analysis. Telomerase enzyme had adequate stability while efficacy, linearity, and reproducibility of TRAP method were acceptable for bio-analytical methods. All this indicated that telomerase could be a reliable biomarker.
Ključne reči:
Telomerase / freezing / reproducibility of results / biomarkers / carcinoma / nuclear magnetic resonanceIzvor:
Scandinavian Journal of Clinical and Laboratory Investigation, 2019, 79, 3, 188-193Izdavač:
- Taylor & Francis Ltd, Abingdon
Finansiranje / projekti:
DOI: 10.1080/00365513.2019.1576220
ISSN: 0036-5513
PubMed: 30767570
WoS: 000465174400006
Scopus: 2-s2.0-85061797797
Institucija/grupa
PharmacyTY - JOUR AU - Vukašinović, Aleksandra AU - Kotur-Stevuljević, Jelena AU - Mlakar, Vid AU - Sopić, Miron AU - Cvetković, Zorica P. AU - Petković, Miloš AU - Spasojević-Kalimanovska, Vesna AU - Bogavac-Stanojević, Nataša AU - Ostanek, Barbara PY - 2019 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/3356 AB - Telomerase is RNA directed polymerase which acts as reverse transcriptase based on its own RNA component. It is considered to be involved in the pathology of many diseases and is recognized as a potential biomarker. The aims were to determine the sample storage conditions and the time frame for samples analysis, then to prove reliability of enzyme activity measurement with real-time telomeric repeat amplification protocol (TRAP) and to evaluate the suitable standard samples for telomerase activity measurements. Samples used for stability and freeze-thaw study were peripheral blood leukocytes, obtained from apparently healthy persons, patients with diagnosed cancer and cell lines. Telomerase activity was measured using TRAP method, while standard evaluation was done using nuclear magnetic resonance (NMR) technique. Storage at -20 degrees C preserved telomerase activity in samples from cancer patients for at least 14 days (21.46 +/- 0.135 versus 21.84 +/- 0.357, p = .756), while samples obtained from healthy persons should be stored at -80 degrees C. We observed significant decrease of telomerase activity at freeze thaw cycle 5 in cancer patients' samples (21.46 +/- 0.135 versus 23.09 +/- 0.316, p lt .05), and in healthy persons' ones already at cycle 3 (22.74 +/- 0.107 versus 24.85 +/- 0.151, p lt .05). Telomerase activity from cell lines samples showed overall greater stability regarding the storage period and freeze-thaw cycles and it was considered for standard sample, which was confirmed by NMR analysis. Telomerase enzyme had adequate stability while efficacy, linearity, and reproducibility of TRAP method were acceptable for bio-analytical methods. All this indicated that telomerase could be a reliable biomarker. PB - Taylor & Francis Ltd, Abingdon T2 - Scandinavian Journal of Clinical and Laboratory Investigation T1 - Telomerase stability and evaluation of real-time telomeric repeat amplification protocol VL - 79 IS - 3 SP - 188 EP - 193 DO - 10.1080/00365513.2019.1576220 ER -
@article{ author = "Vukašinović, Aleksandra and Kotur-Stevuljević, Jelena and Mlakar, Vid and Sopić, Miron and Cvetković, Zorica P. and Petković, Miloš and Spasojević-Kalimanovska, Vesna and Bogavac-Stanojević, Nataša and Ostanek, Barbara", year = "2019", abstract = "Telomerase is RNA directed polymerase which acts as reverse transcriptase based on its own RNA component. It is considered to be involved in the pathology of many diseases and is recognized as a potential biomarker. The aims were to determine the sample storage conditions and the time frame for samples analysis, then to prove reliability of enzyme activity measurement with real-time telomeric repeat amplification protocol (TRAP) and to evaluate the suitable standard samples for telomerase activity measurements. Samples used for stability and freeze-thaw study were peripheral blood leukocytes, obtained from apparently healthy persons, patients with diagnosed cancer and cell lines. Telomerase activity was measured using TRAP method, while standard evaluation was done using nuclear magnetic resonance (NMR) technique. Storage at -20 degrees C preserved telomerase activity in samples from cancer patients for at least 14 days (21.46 +/- 0.135 versus 21.84 +/- 0.357, p = .756), while samples obtained from healthy persons should be stored at -80 degrees C. We observed significant decrease of telomerase activity at freeze thaw cycle 5 in cancer patients' samples (21.46 +/- 0.135 versus 23.09 +/- 0.316, p lt .05), and in healthy persons' ones already at cycle 3 (22.74 +/- 0.107 versus 24.85 +/- 0.151, p lt .05). Telomerase activity from cell lines samples showed overall greater stability regarding the storage period and freeze-thaw cycles and it was considered for standard sample, which was confirmed by NMR analysis. Telomerase enzyme had adequate stability while efficacy, linearity, and reproducibility of TRAP method were acceptable for bio-analytical methods. All this indicated that telomerase could be a reliable biomarker.", publisher = "Taylor & Francis Ltd, Abingdon", journal = "Scandinavian Journal of Clinical and Laboratory Investigation", title = "Telomerase stability and evaluation of real-time telomeric repeat amplification protocol", volume = "79", number = "3", pages = "188-193", doi = "10.1080/00365513.2019.1576220" }
Vukašinović, A., Kotur-Stevuljević, J., Mlakar, V., Sopić, M., Cvetković, Z. P., Petković, M., Spasojević-Kalimanovska, V., Bogavac-Stanojević, N.,& Ostanek, B.. (2019). Telomerase stability and evaluation of real-time telomeric repeat amplification protocol. in Scandinavian Journal of Clinical and Laboratory Investigation Taylor & Francis Ltd, Abingdon., 79(3), 188-193. https://doi.org/10.1080/00365513.2019.1576220
Vukašinović A, Kotur-Stevuljević J, Mlakar V, Sopić M, Cvetković ZP, Petković M, Spasojević-Kalimanovska V, Bogavac-Stanojević N, Ostanek B. Telomerase stability and evaluation of real-time telomeric repeat amplification protocol. in Scandinavian Journal of Clinical and Laboratory Investigation. 2019;79(3):188-193. doi:10.1080/00365513.2019.1576220 .
Vukašinović, Aleksandra, Kotur-Stevuljević, Jelena, Mlakar, Vid, Sopić, Miron, Cvetković, Zorica P., Petković, Miloš, Spasojević-Kalimanovska, Vesna, Bogavac-Stanojević, Nataša, Ostanek, Barbara, "Telomerase stability and evaluation of real-time telomeric repeat amplification protocol" in Scandinavian Journal of Clinical and Laboratory Investigation, 79, no. 3 (2019):188-193, https://doi.org/10.1080/00365513.2019.1576220 . .